310 related articles for article (PubMed ID: 15584119)
21. Alzheimer's drug delays move to nursing home.
Health News; 2003 Nov; 9(11):7. PubMed ID: 14619814
[No Abstract] [Full Text] [Related]
22. Donepezil and Alzheimer's dementia.
Earl-Slater A; Walley T
Clin Perform Qual Health Care; 2000; 8(1):47-51. PubMed ID: 11183967
[No Abstract] [Full Text] [Related]
23. Donepezil (Aricept) therapy for Alzheimer's disease.
Geldmacher DS
Compr Ther; 1997 Jul; 23(7):492-3. PubMed ID: 9262925
[No Abstract] [Full Text] [Related]
24. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
Mizuno S; Kameda A; Inagaki T; Horiguchi J
Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
[TBL] [Abstract][Full Text] [Related]
25. Treating Alzheimer's disease with cholinergic drugs, Part 2.
Terpstra T; Terpstra T
Nurse Pract; 1999 Jan; 24(1):117-9. PubMed ID: 9950002
[No Abstract] [Full Text] [Related]
26. Continuing donepezil when Alzheimer symptoms worsen might delay nursing home admission, study indicates.
Torjesen I
BMJ; 2015 Oct; 351():h5739. PubMed ID: 26506953
[No Abstract] [Full Text] [Related]
27. AD2000: design and conclusions.
Clarke N
Lancet; 2004 Oct 2-8; 364(9441):1215-6; author reply 1216-7. PubMed ID: 15464176
[No Abstract] [Full Text] [Related]
28. Donepezil in the treatment of patients with Alzheimer's disease.
Tsuno N
Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
[TBL] [Abstract][Full Text] [Related]
29. AD2000: design and conclusions.
Howe I
Lancet; 2004 Oct 2-8; 364(9441):1214-5; author reply 1216-7. PubMed ID: 15464174
[No Abstract] [Full Text] [Related]
30. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
31. AD2000: design and conclusions.
Akintade L; Zaiac M; Ieni JR; McRae T
Lancet; 2004 Oct 2-8; 364(9441):1214; author reply 1216-7. PubMed ID: 15464175
[No Abstract] [Full Text] [Related]
32. First drug for moderate-to-severe Alzheimer's.
FDA Consum; 2004; 38(1):3. PubMed ID: 15032183
[No Abstract] [Full Text] [Related]
33. Featured CME topic: dementia. Medication update.
Slagle MA
South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
[No Abstract] [Full Text] [Related]
34. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
[No Abstract] [Full Text] [Related]
35. AD2000: design and conclusions.
Holmes C; Burns A; Passmore P; Forsyth D; Wilkinson D
Lancet; 2004 Oct 2-8; 364(9441):1213-4; author reply 1216-7. PubMed ID: 15464172
[No Abstract] [Full Text] [Related]
36. Response to letter from Garcia and colleagues on cholinesterase inhibitors and Alzheimer's disease outcomes.
Gillette-Guyonnet S; Andrieu S; Nourhashemi F; Reynish E; Vellas B
J Gerontol A Biol Sci Med Sci; 2007 Jun; 62(6):679-80. PubMed ID: 17595427
[No Abstract] [Full Text] [Related]
37. Continuing donepezil produces cognitive benefits in Alzheimer's.
Bland P
Practitioner; 2012 Apr; 256(1750):5. PubMed ID: 22792683
[No Abstract] [Full Text] [Related]
38. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
[TBL] [Abstract][Full Text] [Related]
39. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
Blais L; Kettani FZ; Perreault S; Leroux JC; Forget A; Kergoat MJ
J Am Geriatr Soc; 2009 Feb; 57(2):366-8. PubMed ID: 19207161
[No Abstract] [Full Text] [Related]
40. New drug treatment for Alzheimer's disease. Treatment with metrifonate warrants multicentre trials.
Zamar AC; Wise ME; Watson JP
BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841012
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
